# Mission BioCapital: portfolio, investments and team

> Mission BioCapital is a vc firm based in United States. 52 investments on record, 13 in the last 12 months, latest Sept 2026.

Source: https://millionrounds.com/fund/mission-biocapital (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Mission BioCapital

Last cheque observed Sep 2026; 52 cheques on record.

Deploying now New fund $144M, Nov 2025 VC firm

Seed Series A Series B Lifesciences Medicines Therapeutic

Deploying now

**81%** of best year **13** **cheques in 12 months**, 52 on record

Since the last cheque **48** days **00** hrs **00** min **00** sec

Median round **$33M** Cheque size, as they say **$100K – $5.0M** Rounds led **1 of 52** Sole investor **8 rounds** Mostly in **United States, 87%**

Pitch Mission BioCapital

## Mission BioCapital highlights

- 01 13 cheques in the last 12 months
- 02 Mostly Venture and Series B: 49% of its rounds
- 03 Sole investor in 8 rounds, median $4.7M

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** $100K – $5.0M as they say
- **Stages:** Seed Series A Series B Growth
- **Sectors:** Lifesciences Medicines Therapeutic
- **Based in:** Cambridge, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **52 appearances**

- **2026** 12 rounds
- **Sept** **[Cloverleaf Bio](https://millionrounds.com/company/cloverleaf-bio)** Seed · 4BIO Capital **$33M** With 4 others
- **Sept** **[Breye Therapeutics](https://millionrounds.com/company/breye-therapeutics)** Series A · DK · Sound Bioventures **$77M** With 11 others
- **Aug** **[Integrated Biosciences](https://millionrounds.com/company/integrated-biosciences)** Venture · US **$68M** With 2 others
- **Jul** **[Shape Therapeutics](https://millionrounds.com/company/shape-therapeutics)** Grant · US **$112M** With 2 others
- **Apr** **[Deck Bio](https://millionrounds.com/company/deck-bio)** Seed · US **$3.1M** Sole investor
- **Apr** **[Beech Biotech](https://millionrounds.com/company/beech-biotech)** Seed · CH **$500K** With 1 other
- **Mar** **[TippingPoint Biosciences](https://millionrounds.com/company/tippingpoint-biosciences)** Seed · US **$4.5M** With 1 other
- **Feb** **[Umlaut.Bio](https://millionrounds.com/company/umlaut-bio)** Pre-seed · DE **$3.5M** Sole investor
- **Jan** **[Nocion Therapeutics](https://millionrounds.com/company/nocion-therapeutics)** Series B · US · Lumira Ventures **$23M** With 9 others
- **Jan** **[Mediar Therapeutics](https://millionrounds.com/company/mediar-therapeutics)** Series B · US **$76M** With 2 others
- **Jan** **[Enodia Therapeutics](https://millionrounds.com/company/enodia-therapeutics)** Seed · FR **$24M** With 2 others
- **Jan** **[EpiBiologics](https://millionrounds.com/company/epibiologics)** Series B · US **$107M** With 4 others
- **2025** 9 rounds
- **Nov** **[AI Proteins](https://millionrounds.com/company/ai-proteins)** Series A · US **$42M** With 1 other
- **Oct** **[Zag Bio](https://millionrounds.com/company/zag-bio)** Series A · US · Firms' own news pages **$80M** With 9 others
- **Aug** **[Sensorium Therapeutics](https://millionrounds.com/company/sensorium-therapeutics)** Series A · US **$25M** With 1 other
- **Apr** **[D2B3](https://millionrounds.com/company/d2b3)** Pre-seed · US **$500K** Sole investor
- **Apr** **[March Biosciences](https://millionrounds.com/company/march-biosciences)** Grant · US **$200K** With 2 others
- **Apr** **[Glycomine](https://millionrounds.com/company/glycomine)** Series C · US **$115M** With 2 others
- **Mar** **[Vivace Therapeutics](https://millionrounds.com/company/vivace-therapeutics)** Series D · US **$35M** With 3 others
- **Feb** **[AmbAgon Therapeutics](https://millionrounds.com/company/ambagon-therapeutics)** Venture · US **$5.0M** With 2 others
- **Jan** **[Tune Therapeutics](https://millionrounds.com/company/tune-therapeutics)** Series B · US · Hatteras Venture Partners **$175M** With 5 others
- **2024** 12 rounds
- **Dec** **[Nuvig Therapeutics](https://millionrounds.com/company/nuvig-therapeutics)** Series B · US **$161M** With 4 others
- **Dec** **[SiteOne Therapeutics](https://millionrounds.com/company/siteone-therapeutics)** Series C · US **$100M** With 4 others
- **Dec** **[Alessa Therapeutics](https://millionrounds.com/company/alessa-therapeutics)** Seed · US **$15M** Sole investor
- **Nov** **[Jupiter BioVentures](https://millionrounds.com/company/jupiter-bioventures)** Venture · US **$70M** With 2 others
- **Oct** **[March Biosciences](https://millionrounds.com/company/march-biosciences)** Series A · US · 4BIO Capital **$28M** *Led*
- **Oct** **[Integrated Biosciences](https://millionrounds.com/company/integrated-biosciences)** Seed · US **$17M** With 2 others
- **Sept** **[ImmunOs Therapeutics](https://millionrounds.com/company/immunos-therapeutics)** Series C · CH **$11M** With 4 others
- **Sept** **[Circle Pharma](https://millionrounds.com/company/circle-pharma)** Series D · US **$90M** With 1 other
- **Jul** **[Dren Bio](https://millionrounds.com/company/dren-bio)** Venture · US **$25M** With 4 others
- **May** **[Progentos Therapeutics](https://millionrounds.com/company/progentos-therapeutics)** Series A · US **$65M** With 2 others
- **Mar** **[Nocion Therapeutics](https://millionrounds.com/company/nocion-therapeutics)** Series B · US **$62M** With 1 other
- **Jan** **[Effector Therapeutics](https://millionrounds.com/company/effector-therapeutics)** US **$15M** With 2 others
- **2023** 3 rounds
- **Jun** **[Invenio Imaging](https://millionrounds.com/company/invenio-imaging)** Venture · US **Undisclosed** With 2 others
- **Mar** **[Mediar Therapeutics](https://millionrounds.com/company/mediar-therapeutics)** Series A · US **$85M** With 2 others
- **Mar** **[QurAlis](https://millionrounds.com/company/quralis)** Series B · US **$88M** With 4 others
- **2022** 2 rounds
- **Oct** **[Symbiome](https://millionrounds.com/company/symbiome)** Venture · US **Undisclosed** With 2 others
- **Feb** **[Arkuda Therapeutics](https://millionrounds.com/company/arkuda-therapeutics)** Series B · US **$64M** With 3 others
- **2021** 7 rounds
- **Oct** **[GraphWear Technologies](https://millionrounds.com/company/graphwear-technologies)** Series B · US **$21M** With 2 others
- **Jul** **[Shape Therapeutics](https://millionrounds.com/company/shape-therapeutics)** Series B · US **$112M** With 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **8 named**

CT **Christopher Taylor Carlin** Chief Compliance Officer and COO of Bioinnovation Management LLC i Form ADV

DK **Douglas Kingsley Crawford** General Partner, and Director of Bioinnovation Management LLC i Form ADV

EW **Eric W. Linsley** Managing General Partner and Director, and Series B Member of Bioinnovation Management LLC i Form ADV

JF **Johannes Fruehauf** General Partner and Director and Series B Member of Bioinnovation Management LLC i Form ADV

LM **Loretta Mcclary** Chief Financial Officer, Bioinnovation Management LLC i Form ADV

PD **Peter D. Parker** Managing General Partner, CEO, and Series a and B Member of Bioinnovation Management LLC i Form ADV

SW **Steven Webb Tregay** General Partner and Director of Bioinnovation Management LLC i Form ADV

SH **Susie Harborth** Senior Advisor, Director and Series B Member of Bioinnovation Management LLC i Form ADV

We also hold **17** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$620M** gross assets of its funds, 2 advisers combined Oct 2026

**Exempt** reporting adviser venture or small private funds

- **Legal name:** Mission Biocapital Management Company LLC
- **SEC number:** CRD 283710

## What they claim to have backed

From their own portfolio page (on their website)

**36** of 51 we have independently watched raise

[AI Proteins](https://millionrounds.com/company/ai-proteins)[Alector](https://millionrounds.com/company/alector)[Alessatherapeutics](https://millionrounds.com/company/alessa-therapeutics)[Applaudmedical](https://millionrounds.com/company/applaud-medical)[Asherbio](https://millionrounds.com/company/asher-bio)[Atreca](https://millionrounds.com/company/atreca)[BioLabs](https://millionrounds.com/company/biolabs)[Circlepharma](https://millionrounds.com/company/circle-pharma)[Comettherapeutics](https://millionrounds.com/company/comet-therapeutics)[Drenbio](https://millionrounds.com/company/dren-bio)[Effector](https://millionrounds.com/company/effector-therapeutics)[Epibiologics](https://millionrounds.com/company/epibiologics)[Epiodyne](https://millionrounds.com/company/epiodyne)[Glycomine](https://millionrounds.com/company/glycomine)[Immunostherapeutics](https://millionrounds.com/company/immunos-therapeutics)[Invenio-imaging](https://millionrounds.com/company/invenio-imaging)[Kit](https://millionrounds.com/company/kit)[LabCentral](https://millionrounds.com/company/labcentral)[Logicink](https://millionrounds.com/company/logicink)[Mammoth](https://millionrounds.com/company/mammoth-biosciences)[March Biosciences](https://millionrounds.com/company/march-biosciences)[Nobellfoods](https://millionrounds.com/company/nobell-foods)[Nuvigtherapeutics](https://millionrounds.com/company/nuvig-therapeutics)[Photoswitchbiosciences](https://millionrounds.com/company/photoswitch-biosciences)[Progentos Therapeutics](https://millionrounds.com/company/progentos-therapeutics)[Quralis](https://millionrounds.com/company/quralis)[Sensorium Therapeutics](https://millionrounds.com/company/sensorium-therapeutics)[Siteonetherapeutics](https://millionrounds.com/company/siteone-therapeutics)[Sound](https://millionrounds.com/company/sound)[Symbiome](https://millionrounds.com/company/symbiome)[Symic](https://millionrounds.com/company/symic-bio)[Tangiblescience](https://millionrounds.com/company/tangible-science)[Vaxess](https://millionrounds.com/company/vaxess-technologies)[Vivacetherapeutics](https://millionrounds.com/company/vivace-therapeutics)[Wildtypefoods](https://millionrounds.com/company/wild-type)[Zymergen](https://millionrounds.com/company/zymergen) Arasetherapeutics Avexegen Calithera Cariboubio Cavalry Biosciences CookieYes Eikonizo Fluxionbio Jupiter MBC BioLabs Magnapsleepapnea Myka Principiabio Vederebio Zephyrusbio

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

New fund on file

**$144M**

raised in Nov 2025

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$33M** the round, not its cheque Alone, median **$4.7M**

Led 1 of 52 rounds **2%**

- **Said size:** $100K – $5.0M
- **Sole investor:** 8 rounds
- **Last cheque:** Sept 2026

Rounds by stage said on their site

- Venture *12*
- Series B said *11*
- Series A said *9*
- Seed said *8*
- Series C *4*
- Grant *3*
- Growth said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Alexandria Venture Investments](https://millionrounds.com/fund/alexandria-venture-investments) 4
- [Canaan](https://millionrounds.com/fund/canaan-partners) 4
- [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 4
- [Novo Holdings](https://millionrounds.com/fund/novo-ventures) 4
- [AbbVie](https://millionrounds.com/fund/abbvie) 3
- [KdT Ventures](https://millionrounds.com/fund/kdt-ventures) 3

**Pitching Mission BioCapital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Mission BioCapital. A count of rooms they were both in, not a relationship either has claimed.

[**Alexandria Venture Investments** VC firm **4** rounds together](https://millionrounds.com/fund/alexandria-venture-investments)[**Canaan** VC firm **4** rounds together](https://millionrounds.com/fund/canaan-partners)[**New Enterprise Associates** VC firm **4** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Novo Holdings** VC firm **4** rounds together](https://millionrounds.com/fund/novo-ventures)[**AbbVie** Corporate VC **3** rounds together](https://millionrounds.com/fund/abbvie)[**KdT Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/kdt-ventures)[**Polaris Partners** VC firm **3** rounds together](https://millionrounds.com/fund/polaris-partners)[**Samsara BioCapital** VC firm **3** rounds together](https://millionrounds.com/fund/samsara-biocapital)[**Sanofi** Investment firm **3** rounds together](https://millionrounds.com/fund/sanofi)[**Sofinnova Partners** VC firm **3** rounds together](https://millionrounds.com/fund/sofinnova-partners)[**4BIO Capital** VC firm **2** rounds together](https://millionrounds.com/fund/4bio-capital)[**Atlas Venture** VC firm **2** rounds together](https://millionrounds.com/fund/atlas-venture)

## Recently backed

The latest companies Mission BioCapital put money into.

[**Cloverleaf Bio** $33M · Sept 2026](https://millionrounds.com/company/cloverleaf-bio)[**Integrated Biosciences** $68M · Aug 2026](https://millionrounds.com/company/integrated-biosciences)[**Shape Therapeutics** $112M · Jul 2026](https://millionrounds.com/company/shape-therapeutics)[**Deck Bio** $3.1M · Apr 2026](https://millionrounds.com/company/deck-bio)[**TippingPoint Biosciences** $4.5M · Mar 2026](https://millionrounds.com/company/tippingpoint-biosciences)[**Nocion Therapeutics** $23M · Jan 2026](https://millionrounds.com/company/nocion-therapeutics)

## Quick answers about Mission BioCapital

### What does Mission BioCapital invest in?

Mission BioCapital invests most often at Venture and Series B (49% of the rounds on record), in sectors such as Lifesciences, Medicines and Therapeutic.

### How active is Mission BioCapital?

52 investments on record, 13 of them in the last 12 months, and it led 1. The most recent was in Sept 2026.

### What has Mission BioCapital invested in recently?

Its most recent investments on record: Cloverleaf Bio (Seed, Sept 2026), Breye Therapeutics (Series A, Sept 2026) and Integrated Biosciences (Venture, Aug 2026).

### How big are Mission BioCapital's cheques?

The median round it joins is $33M. It says it writes cheques of $100K to $5.0M.

### Does Mission BioCapital lead rounds?

Sometimes: it led 1 of its 52 investments on record (2%).

### Where does Mission BioCapital invest?

Most of the companies it backs are in the United States (87%) and Switzerland (5%).

### Is Mission BioCapital investing now?

Yes: it is actively investing, with 13 investments in the last 12 months.

### Who does Mission BioCapital invest alongside?

Most often Alexandria Venture Investments (4 rounds together), Canaan (4 rounds together) and New Enterprise Associates (4 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=mission-biocapital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=mission-biocapital)